Anthony Floyd, PhD

Anthony is a Research Associate Professor, providing clinical trial and regulatory expertise in the treatment and prevention of substance use disorder, in particular opioid use disorder. He has directed numerous clinical trials and program evaluations in both community treatment and emergency department settings. Dr. Floyd has a secondary focus in firearm injury prevention research, which examines many of the same underlying public health concerns as substance use disorder. In addition, Anthony leads a team from Washington in a multi-site, multi-state study, examining the effectiveness of an opioid safety and education training program aimed at pharmacists in community-based settings.

Department Affiliations

Recent Publications

"I go out of my way to give them an extra smile now:" A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials.
(2024 May)
Res Social Adm Pharm 20(5): 512-519
Irwin AN, Gray M, Ventricelli D, Boggis JS, Bratberg J, Floyd AS, Silcox J, Hartung DM, Green TC

The Cost of Safe Injection: Insights on Nonprescription Syringe Price Variability From Systematic Secret Shopping.
(2024 Apr)
Subst Use Addctn J 45(2): 201-210
Blough MJ, Rocha A, Bratberg J, Silcox J, Bolivar D, Floyd AS, Gray M, Green TC

The Community-Based Medication-First program for opioid use disorder: a hybrid implementation study protocol of a rapid access to buprenorphine program in Washington State.
(2022 Jul 7)
Addict Sci Clin Pract 17(1): 34
Banta-Green CJ, Owens MD, Williams JR, Sears JM, Floyd AS, Williams-Gilbert W, Kingston S

Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies.
(2022)
Subst Abus 43(1): 901-905
Green TC, Bratberg J, Irwin AN, Boggis J, Gray M, Leichtling G, Bolivar D, Floyd A, Al-Jammali Z, Arnold J, Hansen R, Hartung D

Barriers to recruitment, retention and intervention delivery in a randomized trial among patients with firearm injuries.
(2021 Jul 26)
Inj Epidemiol 8(1): 37
Floyd AS, Lyons VH, Whiteside LK, Haggerty KP, Rivara FP, Rowhani-Rahbar A

Show complete publication list »
Edit Profile